Medical Equipment Startup Pulse Raises $4M Led by 3one4 Capital to Boost India’s MedTech Capabilities

India’s healthcare innovation landscape is witnessing focused investments in the development of critical medical infrastructure. Pulse, a Bengaluru-based medical equipment startup, has raised $4 million in funding led by India-focused venture capital firm 3one4 Capital, with participation from Incubate Fund Asia, Stride Ventures, and several angel investors. This latest infusion comes at a time when domestic manufacturing of medical devices is gaining urgency amid ongoing efforts to reduce import dependence and improve healthcare access.

Founded in 2025 by Anshul Sharma and Nishant Goel, Pulse focuses on the design and production of medical devices for critical, renal, and cardiac care. Instead of building traditional production lines, the startup partners with nearly 20 MSMEs (micro, small, and medium enterprises) across regions such as Delhi-NCR, Jammu, Gujarat, Kolkata, and Mumbai to co-manufacture key products, such as blood tubing sets and anesthesia machines.

Filling a Critical Gap in Healthcare Manufacturing

According to the founders, many Indian MSMEs have strong manufacturing capabilities but lack structured research and development, regulatory clarity, and quality assurance processes needed to compete with global device producers. Pulse aims to bridge that gap by providing manufacturing partners with R&D frameworks, compliance systems, and quality infrastructure, effectively enabling them to scale production and move up the value chain.

“Medical equipment calls for sustained investment in quality, compliance, and brand building,” said Pulse co-founder Anshul Sharma in a recent interview, highlighting the structural challenges faced by domestic manufacturers. Pulse’s model seeks to address these pain points by strengthening in-house design, quality assurance, and distribution support.

Strategic Use of Capital

Pulse plans to deploy the fresh capital to:

• Accelerate product development and expand its device portfolio
• Secure key regulatory certifications to enhance market credibility
• Set up a new R&D hub in Vizag (Andhra Pradesh), expected to begin operations by March 2026
• Build stronger distribution networks serving mid-tier and larger hospital markets across India

This strategy reflects a growing trend among healthcare startups to invest in deep product and quality capabilities — especially for devices that are essential to critical care frameworks.

Broader Context: MedTech and India’s Healthcare Ecosystem

India has historically relied heavily on imported medical devices, particularly for critical care, cardiology, and renal support systems. However, supportive government policies, such as the National Medical Devices Policy and the Production Linked Incentive (PLI) scheme, aim to foster domestic manufacturing and reduce import dependency.

In this environment, startups like Pulse — with a manufacturing-led, quality-centric approach — could play a pivotal role in strengthening India’s medical technology ecosystem and lowering costs for hospitals and patients alike.

Disclaimer

This article is based on publicly available media reports and industry sources. Information is provided for informational purposes only. Kalpway does not independently verify the accuracy or completeness of the sources cited, and this content should not be construed as financial or investment advice.